Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome.

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Abstract Text:

Michael Friedman,Hsin-Ching Lin,Berk Gurpinar,Ninos J Joseph,

OBJECTIVES: To assess subjective and objective improvement after single-stage multilevel minimally invasive treatment for obstructive sleep apnea/hypopnea syndrome (OSAHS). STUDY DESIGN: A retrospective review of a prospective dataset of patients treated in a tertiary care referral center. METHODS: Charts of 145 patients with mild/moderate OSAHS treated with a single-stage multilevel minimally invasive technique were reviewed to abstract pre- and posttreatment symptoms and polysomnographic data. One hundred twenty-two patients had minimum follow-up of 6 (range, 6-23) months and complete data available for analysis. All patients studied had three-level treatment that included nasal surgery, palatal stiffening by Pillar implant technique, and radiofrequency volume reduction of the tongue base. Primary outcomes included change from baseline in apnea/hypopnea index (AHI). Secondary outcomes included change in Epworth Sleepiness Scale (ESS) and bed-partner assessed snoring visual analogue scale (VAS, 0-10), pain levels, narcotic use, and complications. RESULTS: Mean AHI decreased from 23.2 +/- 7.6 preoperatively to 14.5 +/- 10.2 postoperatively (P < .0001). Classical "cure" was achieved in 54 (47.5%) patients. Mean ESS decreased from 9.7 +/- 3.9 preoperatively to 6.9 +/- 3.3 postoperatively (P < .0001). Mean snoring VAS decreased from 9.4 +/- 0.9 preoperatively to 3.2 +/- 2.4 postoperatively (P <. 0001). CONCLUSION: Polysomnographic respiratory parameters, ESS, and snoring VAS significantly improved in patients with mild/moderate OSAHS treated with single-stage multilevel minimally invasive surgery. Multilevel minimally invasive single-stage surgery is a valid option for selected patients with mild/moderate OSAHS with the understanding that they may require secondary treatment.

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Publishing Authors By Initials

M Friedman,HC Lin,B Gurpinar,NJ Joseph,

For similar surgical procedures, operative: surgical procedures, minimally invasive research abstracts see: surgical procedures, operative: surgical procedures, minimally invasive research

PUBMED ID PMID:

MEDLINE DATE:

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Laryngoscope

VOLUME: 117

Page Numbers: 1859-63

Journal Abbreviation: Laryngoscope

ISSN: 0023-852X

DAY: 19

MONTH: Oct

YEAR: 2007

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8607378

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Keywords Mesh Terms:

KEYWORDS: Surgical Procedures, Minimally Invasive

MESH TERMS: methods

Chemical & Substance for Abstract: Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome.

AFFILIATION: Department of Otolaryngology and Bronchoesophagology, Rush University Medical Center, Chicago, Illinois, USA. hednnek@aol.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Laryngoscope

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome Related Publications

• Binding of mRNA to the bacterial translation initiation complex.
• Biodiesel concerns.
• Functional Genomics of Wine Yeast Saccharomyces cerevisiae.
• Functional dissociation in frontal and striatal areas for processing of positive and negative reward information.
• Huntington's disease like-2 neuropathology.
• Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho.
• In appreciation.
• In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
• MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
• Managing Legionnaires' disease in Europe: the need for international collaboration.
• Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome.
• Mirtazapine-induced nightmares.
• Neuropsychological frameworks for understanding autism.
• Nutritional interventions in aging and age-associated diseases.
• Paradoxical ozone associations could be due to methyl nitrite from combustion of methyl ethers or esters in engine fuels.
• Patient-reported validated functional outcome after extraperitoneal robotic-assisted nerve-sparing radical prostatectomy.
• Pediatric urodynamics: basic concepts for the neurosurgeon.
• Performance of bioreactor landfill with waste mined from a dumpsite.
• Post-traumatic stress disorder and smoking: A systematic review.
• Providing customized services Concierge services put patients' and employees' minds at ease.
• Randomized comparison of extraperitoneal and transperitoneal access for robot-assisted radical prostatectomy.
• Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy.
• Role of inositol 1,4,5-trisphosphate receptors in apoptosis in DT40 lymphocytes.
• Should nonatopic asthma get equal attention?
• The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion.
• The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
• The development of expert face processing: are infants sensitive to normal differences in second-order relational information?
• The stem cell army in heart failure: do we mobilize or pave the way home?
• US Black vs White disparities in foetal growth: physiological or pathological?
• Update on the treatment of diabetic foot infections.